- Clone:
- REAL565
- Type of antibody:
- Releasable fluorochromes, Primary antibodies, Recombinant antibodies
- Applications:
- MICS, IF, IHC Glossary
- Select a conjugate:
Related products for CD107a (LAMP-1) Antibody, anti-human, REAdye_lease™
A
B
A
B
Clone REAL565 is an antibody fragment derived from the full CD107a antibody molecule. It displays no binding to Fc receptors. The recombinantly engineered antibody fragments are multimerized to form the REAdye_lease Complex to bind markers with high avidity.
Clone REAL565 recognizes the CD107a antigen, also known as lysosome-associated membrane protein 1 (LAMP-1), a 110–140 kDa type I membrane glycoprotein. It is a widely expressed intracellular protein, located in the lysosomal/endosomal membrane. CD107a transiently located on the plasma membrane can be used as a marker for CD8+ T cell degranulation following stimulation. It is also expressed to a lower extent on activated NK cells.
For removal of REAdye_lease fluorochromes for optional relabeling with different fluorochrome-conjugated REAdye_lease antibodies use the REAlease Support Kit (130-120-675).
LAMP-1, LAMPA, LGP120, LAMP1
Technical specifications
To access a Certificate of Analysis (CoA) follow the link below and enter the specific lot of your product.
Should you wish to request additional documentation, such as a Safety Data Sheet (SDS) in other languages than English or Swedish, an SDS-replacement document, or a Certificate of Origin (CoO), please direct your inquiry to your local technical support team.
- Wang, Q. et al. (2017) LAMP1 expression is associated with poor prognosis in breast cancer. Oncol Lett 14 (4): 4729-4735
- Betts, M. R. et al. (2003) Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J. Immunol. Methods 281: 65-78
- Mane, S. M. et al. (1989) Purification and characterization of human lysosomal membrane glycoproteins. Arch Biochem Biophys. 268 (1): 360-378